1.
Alectinib in ALK -positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
by Shaw, Alice T, Dr
The lancet oncology, 2016, Vol.17 (2), p.234-242

2.
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
by Shaw, Alice T, Dr
The lancet oncology, 2011, Vol.12 (11), p.1004-1012

3.
Response assessment criteria for brain metastases: proposal from the RANO group
by Lin, Nancy U, Dr
The lancet oncology, 2015, Vol.16 (6), p.e270-e278

4.
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
by Lin, Nancy U, Dr
The lancet oncology, 2013, Vol.14 (10), p.e407-e416

5.
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
by Lin, Nancy U, Dr
The lancet oncology, 2013, Vol.14 (10), p.e396-e406

6.
Simulation studies of vestibular macular afferent-discharge patterns using a new, quasi-3-D finite volume method
by Ross, M. D.
Journal of computational neuroscience, 2000, Vol.8 (1), p.5-18

7.
“Med-X”: a medical examiner surveillance model for bioterrorism and infectious disease mortality
by Nolte, Kurt B., MD
Human pathology, 2007, Vol.38 (5), p.718-725

8.
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
by Abbate, Antonio, MD, PhD
The American journal of cardiology, 2015, Vol.115 (3), p.288-292

9.
Is eczema really on the increase worldwide?
by Williams, Hywel, PhD
Journal of allergy and clinical immunology, 2008, Vol.121 (4), p.947-954.e15

10.
Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
by Castells, Mariana C., MD, PhD
Journal of allergy and clinical immunology, 2008, Vol.122 (3), p.574-580

11.
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-esca...
by Iveson, Timothy, Dr
The lancet oncology, 2014, Vol.15 (9), p.1007-1018

12.
Impact of Atrial Fibrillation and Heart Failure, Independent of Each Other and in Combination, on Mortality in Community-Dwelling Older Adults
by Bajaj, Navkaranbir S., MD
The American journal of cardiology, 2014, Vol.114 (6), p.909-913

13.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicent...
by Gianni, Luca, Dr
The lancet oncology, 2012, Vol.13 (1), p.25-32

14.
Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial
by Cox, Timothy M, Prof
The Lancet (British edition), 2015, Vol.385 (9985), p.2355-2362

15.
Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure
by Canada, Justin McNair, MS
The American journal of cardiology, 2016, Vol.117 (1), p.116-120

16.
Gestational trophoblastic disease
by Seckl, Michael J, Prof
The Lancet (British edition), 2010, Vol.376 (9742), p.717-729

17.
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase...
by Neoptolemos, John P, Prof
The Lancet (British edition), 2017, Vol.389 (10073), p.1011-1024

18.
Translational implications of somatic genomics in acute myeloid leukaemia
by Meyer, Sara C, PhD
The lancet oncology, 2014, Vol.15 (9), p.e382-e394

19.
FCER2 : A pharmacogenetic basis for severe exacerbations in children with asthma
by Tantisira, Kelan G., MD, MPH
Journal of allergy and clinical immunology, 2007, Vol.120 (6), p.1285-1291

20.
Implementation of open and closed kinetic chain quadriceps strengthening exercises after anterior cruciate ligament reconstruction
by Ross, M D
Journal of strength and conditioning research, 2001, Vol.15 (4), p.466-473
